Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 90033 · Class III · LifeShare Blood Centers
Key facts
| Event ID | 90033 |
|---|---|
| Recall numbers | B-0338-2022 |
| Recalling firm | LifeShare Blood Centers |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Red Blood Cells, with a positive initial screen for Syphilis and a negative confirmation test, were distributed. |
| Initiation date | Mar 4, 2022 |
| Report date | May 18, 2022 |
| Termination date | May 9, 2022 |
| City | Shreveport |
| State | LA |
| Country | United States |
| FEI number | 2370879 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: